Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  8, 1288 - 1295 (2002)
Published online: 7 October 2002; | doi:10.1038/nm788

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

T. Yamauchi1, 2, 8, J. Kamon1, 8, Y. Minokoshi3, Y. Ito1, H. Waki1, 2, S. Uchida1, S. Yamashita1, M. Noda2, 4, S. Kita1, K. Ueki1, K. Eto1, 2, Y. Akanuma2, 4, P. Froguel5, F. Foufelle6, P. Ferre6, D. Carling7, S. Kimura1, R. Nagai1, B.B. Kahn3 & T. Kadowaki1, 2

1  Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

2  CREST of Japan Science and Technology Corporation, Saitana, Japan

3  Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

4  Institute for Diabetes Care and Research, Asahi Life Foundation, Tokyo, Japan

5  Institute of Biology-CNRS, Pasteur Institute of Lille, Lille, France

6  U465 INSERM, Centre de Recherches Biomedicales des Cordeliers, Paris Cedex, France

7  The Cellular Stress Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, UK

8  T.Y. and J.K. contributed equally to this study.

Correspondence should be addressed to T. Kadowaki kadowaki-3im@h.u-tokyo.ac.jp
Adiponectin (Ad) is a hormone secreted by adipocytes that regulates energy homeostasis and glucose and lipid metabolism. However, the signaling pathways that mediate the metabolic effects of Ad remain poorly identified. Here we show that phosphorylation and activation of the 5'-AMP-activated protein kinase (AMPK) are stimulated with globular and full-length Ad in skeletal muscle and only with full-length Ad in the liver. In parallel with its activation of AMPK, Ad stimulates phosphorylation of acetyl coenzyme A carboxylase (ACC), fatty-acid oxidation, glucose uptake and lactate production in myocytes, phosphorylation of ACC and reduction of molecules involved in gluconeogenesis in the liver, and reduction of glucose levels in vivo. Blocking AMPK activation by dominant-negative mutant inhibits each of these effects, indicating that stimulation of glucose utilization and fatty-acid oxidation by Ad occurs through activation of AMPK. Our data may provide a novel paradigm that an adipocyte-derived antidiabetic hormone, Ad, activates AMPK, thereby directly regulating glucose metabolism and insulin sensitivity in vitro and in vivo.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Nature Reviews Drug Discovery Review (01 Apr 2004)
 See all 2 matches for Reviews

RESEARCH
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Nature Letters to Editor (12 Jun 2003)
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
Nature Letters to Editor (01 Apr 2004)
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Nature Letters to Editor (17 Jan 2002)
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
Nature Medicine Article (01 Aug 2001)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy